drugset / Trial / NCT00836875
A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children
Non-randomizedOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety profile of voriconazole (an antifungal drug) when used in children who have invasive aspergillosis (IA) and other rare systemic fungal infections.
Timeline
- Start
- 2009-05
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Voriconazole | Small molecule | 4 mg/kg | Intravenous |
| Subject | Voriconazole | Small molecule | 8 mg/kg | Intravenous |
| Subject | Voriconazole | Small molecule | 9 mg/kg | Intravenous |
| Subject | Voriconazole | Small molecule | 200 mg | Intravenous |